Experiences with
Small lymphocytic lymphoma (SLL)808 public posts
"Accelerated" chronic lymphocytic leukemia/small lymphocytic lymphoma: unraveling CLL/SLL biological gray zone in the era of novel therapies
leukemia/small lymphocytic lymphoma (A-CLL/SLL) is a histologically aggressive subtype of CLL/SLL that lies in between conventional CLL/SLL (C-CLL/SLL) and Richter transformation (RT) on the biological spectrum.
Want to take advantage of all our features? Just log in!
or
Review article summarises management strategies for those with CLL harbouring complex karyotype
On 6 January 2025, the journal [i]BJ Haem[/i] published a review article titled [i]Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype[/i] written by a team from Padua, Italy. The article summary explains its aims:
[i]"Chronic lymphocytic leukaemia
Wednesday's Word
[u][i]Golexanolone[/i][/u]
[i]A relatively new drug that is in clinical trial mostly being tested to help relieve cognitive and motor functions. It is hopefully to be used for Parkinson patients as well as those with hepatic encephalopathy in PBC. it was being tested in the laboratories
Interactive Tool for Managing BTK Inhibitor−Associated AEs in Hematologic Malignancies: A Global Perspective
Chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
Mantle cell lymphoma (MCL)
Marginal zone lymphoma (MZL)
Waldenström macroglobulinemia (WM)
Has your patient already begun treatment with a BTK inhibitor?